Sean F. Moran, CFO of Corbus Pharmaceuticals Holdings ($CRBP), made two open market sales of company shares over the last year, totaling about $258,000. His latest sale occurred on February 13, 2026. These transactions rank 7,887th among 11,678 insiders in our database by sale value, well below the average of $8.6 million across 6 transactions per insider. Moran recorded no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 4701 | $7.78 | 96,694.0000 | 17,553,037 | 4.64% | 0.03% |
| Jan. 14, 2026 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Stock options (right to buy) | 84247 | $0.00 | 84,247.0000 | 17,553,037 | 9999.99% | 0.48% |
| Jan. 14, 2026 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Common Stock, par value $0.0001 per share | 28082 | $0.00 | 101,395.0000 | 17,553,037 | 38.30% | 0.16% |
| Oct. 24, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Common Stock, par value $0.0001 per share | 12981 | $4.26 | 86,294.0000 | 12,232,228 | 17.71% | 0.11% |
| Oct. 24, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Stock options (right to buy) | 12981 | $0.00 | 10,386.0000 | 12,232,228 | 55.55% | 0.11% |
| Oct. 24, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 12981 | $17.02 | 73,313.0000 | 12,232,228 | 15.04% | 0.11% |
| Feb. 14, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 2792 | $8.76 | 73,313.0000 | 0 | 3.67% | 0.00% |
| Jan. 31, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Common Stock, par value $0.0001 per share | 27500 | $0.00 | 76,105.0000 | 0 | 56.58% | 0.00% |
| Jan. 31, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Stock options (right to buy) | 92500 | $0.00 | 92,500.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Common Stock, par value $0.0001 per share | 1958 | $30.00 | 50,563.0000 | 0 | 4.03% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 1958 | $42.12 | 48,605.0000 | 0 | 3.87% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Options to purchase common stock | 1567 | $0.00 | 1,958.0000 | 0 | 44.45% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Options to purchase common stock | 7788 | $0.00 | 23,367.0000 | 0 | 25.00% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Options to purchase common stock | 6730 | $0.00 | 11,217.0000 | 0 | 37.50% | 0.00% |
| June 18, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Options to purchase common stock | 1958 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Common Stock, par value $0.0001 per share | 6730 | $14.10 | 55,335.0000 | 0 | 13.85% | 0.00% |
| June 17, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 6730 | $46.77 | 48,605.0000 | 0 | 12.16% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 7788 | $49.87 | 48,605.0000 | 0 | 13.81% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Common Stock, par value $0.0001 per share | 7788 | $4.26 | 56,393.0000 | 0 | 16.02% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | S | Common Stock, par value $0.0001 per share | 1567 | $49.87 | 48,605.0000 | 0 | 3.12% | 0.00% |
| June 14, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Common Stock, par value $0.0001 per share | 1567 | $30.00 | 50,172.0000 | 0 | 3.22% | 0.00% |
| April 10, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Employee Stock Option (right to buy) | 1787 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 10, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | M | Common Stock | 1787 | $30.00 | 48,605.0000 | 0 | 3.82% | 0.00% |
| Feb. 12, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Common Stock, par value $0.0001 per share | 40176 | $0.00 | 46,818.0000 | 0 | 604.88% | 0.00% |
| Feb. 12, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Stock Option (right to buy) | 40176 | $0.00 | 40,176.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2023 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Moran Sean F. | Chief Financial Officer | A | Stock Option (right to buy) | 934645 | $0.00 | 934,645.0000 | 0 | 9999.99% | 0.00% |